Respiratory Devices Global Market - Forecast to 2026

Publishing Date : September, 2019
Report Code : HCMD 0128
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others are increasing due to tobacco smoking, second-hand smoking, vehicular smoke emissions, urbanization, industrializations and changing lifestyle. To control these conditions the usage of respiratory devices are rising. The Respiratory care device is one of the parts of medical device which is used for diagnosis, treatment and monitoring purpose. The respiratory care device global market is segmented based on the products, applications, end-users, and geography. Globally respiratory care devices market is showing rapid growth and also in coming years continuing to evolve in the field of research, development, and manufacturing due to its wide range of driving factors such as the increase in the incidence of respiratory diseases, rising use of non-invasive respiratory care devices and growing demand for homecare respiratory devices.

According to IQ4I analysis, the respiratory care devices global market is expected to grow at high single digit CAGR from 2019 to 2026 to reach $23,510.9 million by 2026. Respiratory care devices products market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. The therapeutic devices market commanded the largest share in 2019, and the market is expected to grow at a strong single digit CAGR from 2019 to 2026.

The therapeutic devices product market is segmented into humidifiers, nebulizers, oxygen concentrators, PAP devices, resuscitators, ventilators, inhalers and others. According to IQ4I analysis, among therapeutic devices segment, ventilators commanded the largest revenue in 2019, the market is expected to grow at a mid single digit CAGR from 2019 to 2026. The PAP devices are expected to grow at a strong double digit CAGR from 2019 to 2026. The monitoring devices market is expected to grow at a mid single digit CAGR from 2019 to 2026. The monitoring devices are segmented into pulse oximeter, capnographs and gas analyzers. The pulse oximeters commanded the largest revenue in 2019 and the capnographs are expected to grow at a strong single digit CAGR from 2019 to 2026. The diagnostic devices are expected to grow at a mid single digit CAGR from 2019 to 2026. The diagnostic devices are segmented into spirometers, peak flow meters and polysomnographs, among these, spirometers commanded the largest share in 2019, peak flow meters are expected to grow at a single digit CAGR from 2019 to 2026. The consumables market is expected to grow at a single digit CAGR from 2019 to 2026. The consumables are segmented based on product into masks, nasal cannula, treachostomy devices and others. Mask commanded the largest revenue is expected to grow at a high single digit CAGR from 2019 to 2026.

The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026. The obstructive respiratory conditions are further segmented into COPD (chronic broinchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, the COPD commanded the largest share of the market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.

The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2019. Globally, admission to emergency care is increasing due to respiratory disorder burdens and majorly respiratory therapists are treating more number of patients in these care settings. The Homecare setting is expected to grow at a strong single digit CAGR from 2019 to 2026. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The convenient and comfort at homecare environment, cost of the devices, rental respiratory devices, oxygen resupply systems and other factors shifting the hospital care environment to homecare environment. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2019. The sleep centers are expected to grow at strong single digit CAGR from 2019 to 2026.

The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026 due to advancements in technology, demand for a respiratory disorder, healthcare expenditures by government reforms, and availability of skilled labors. Asia-Pacific is expected to grow at a strong double digit CAGR from 2019 to 2026. Asia-Pacific tends to be fastest-growing segment due to increase in investments in the healthcare sector and emerging economies which creates new opportunities. The other factors influencing are incorporating new technologies, growing health awareness, expansion in healthcare industry, fast economic growth, increasing aging populations, High prevalence of tobacco smoking, Increasing medical expenditure, and health awareness improvements.

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT SCOPE
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET CRACKDOWN AND DATATRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET OVERVIEW
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
    • 3.4     MARKET DYNAMICS
      • 3.4.1     DRIVERS AND OPPORTUNITIES
        • 3.4.1.1     Rising incidences of respiratory diseases due to urbanization and air pollution
        • 3.4.1.2     Increasing tobacco usage
        • 3.4.1.3     Rising use of non-invasive respiratory care devices
        • 3.4.1.4     Growing demand for home care respiratory devices
        • 3.4.1.5     Advancements of technology
        • 3.4.1.6     A huge pool of undiagnosed patients
        • 3.4.1.7     Favorable reimbursement scenario
      • 3.4.2     RESTRAINTS AND THREATS
        • 3.4.2.1     Product recalls
        • 3.4.2.2     Harmful effects of certain devices on neonates
        • 3.4.2.3     Availability of low-cost products from local manufacturers
        • 3.4.2.4     Stringent regulatory policies
        • 3.4.2.5     Lack of awareness of the disease
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     INDIA
      • 3.5.4     CHINA
      • 3.5.5     JAPAN
      • 3.5.6     ISO STANDARDS
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     COMPETITIVE RIVALRY
      • 3.6.4     BARGAINING POWER OF SUPPLIERS
      • 3.6.5     BARGAINING POWER OF BUYERS
    • 3.7     MARKET SHARE ANALYSIS
      • 3.7.1     RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE
      • 3.7.2     VENTILATOR GLOBAL MARKET SHARE ANALYSIS
      • 3.7.3     PAP GLOBAL MARKET SHARE ANALYSIS
      • 3.7.4     CPAP GLOBAL MARKET SHARE ANALYSIS
      • 3.7.5     APAP GLOBAL MARKET SHARE ANALYSIS
      • 3.7.6     BPAP GLOBAL MARKET SHARE ANALYSIS
    • 3.8     OTHER SUPPORTIVE RESPIRATORY DEVICES
      • 3.8.1     SNORING DEVICE
      • 3.8.2     NEUROMODULATION-BREATHING DISORDER (OBSTRUCTIVE SLEEP APNEA)
    • 3.9     REIMBURSEMENT SCENARIO
    • 3.10     TECHNOLOGICAL ADVANCEMENTS
      • 3.10.1     INTEGRATED DEVICES
      • 3.10.2     REMOTE MONITORING
      • 3.10.3     MOBILE OXYGEN CONCENTRATOR
      • 3.10.4     MINIATURIZATION
      • 3.10.5     WIRELESS TECHNOLOGY
      • 3.10.6     WEARABLE TECHNOLOGY
      • 3.10.7     HYPERSONIC NEBULIZER
      • 3.10.8     DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES
    • 3.11     UPCOMING TECHNOLOGY
    • 3.12     FUNDING SCENARIO
    • 3.13     RESPIRATORY CARE DEVICES - DEALS
    • 3.14     PRODUCT LAUNCH, APPROVALS AND PATENT GRANTS
    • 3.15     CLINICAL TRIALS
    • 3.16     SUPPLY CHAIN ANALYSIS
  • 4     RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     THERAPEUTIC RESPIRATORY CARE DEVICES
      • 4.2.1     HUMIDIFIERS
        • 4.2.1.1     Active Humidifiers
        • 4.2.1.2     Passive Humidifiers
      • 4.2.2     NEBULIZERS
        • 4.2.2.1     Jet Nebulizer
        • 4.2.2.2     Ultrasonic Nebulizer
        • 4.2.2.3     Mesh Nebulizer
        • 4.2.2.4     Smart Nebulizer
      • 4.2.3     OXYGEN CONCENTRATORS
        • 4.2.3.1     Stationary Oxygen Concentrators
        • 4.2.3.2     Portable Oxygen Concentrators
      • 4.2.4     POSITIVE AIRWAY PRESSURE DEVICES (PAP)
        • 4.2.4.1     Continuous PAP Devices (CPAP)
        • 4.2.4.2     Automatic PAP (APAP) Devices
        • 4.2.4.3     Bi-Level PAP (BPAP) Devices
      • 4.2.5     RESUSCITATORS
        • 4.2.5.1     Manual Resuscitator
        • 4.2.5.2     Gas Powered Resuscitator
      • 4.2.6     VENTILATORS
        • 4.2.6.1     Non-Invasive Ventilators
        • 4.2.6.2     Invasive Ventilators
      • 4.2.7     VENTILATOR MARKET BY END-USERS
      • 4.2.8     INHALERS
        • 4.2.8.1     Dry Powder Inhalers
        • 4.2.8.2     Metered Dose Inhaler
        • 4.2.8.3     Soft Mist Inhaler
      • 4.2.9     OTHERS
    • 4.3     MONITORING RESPIRATORY CARE DEVICES
      • 4.3.1     PULSE OXIMETERS
        • 4.3.1.1     Finger Pulse Oximeters
        • 4.3.1.2     Handheld Pulse Oximeters
        • 4.3.1.3     Wrist Pulse Oximeters
        • 4.3.1.4     Tabletop Pulse Oximeters
      • 4.3.2     CAPNOGRAPHS
      • 4.3.3     GAS ANALYZERS
    • 4.4     DIAGNOSTIC RESPIRATORY CARE DEVICES
      • 4.4.1     SPIROMETERS
        • 4.4.1.1     Volumetric Spirometers
        • 4.4.1.2     Flow Measuring Spirometers
      • 4.4.2     PEAK FLOW METERS
      • 4.4.3     POLYSOMNOGRAPH DEVICES (PSG)
        • 4.4.3.1     Clinical Polysomnography Devices
        • 4.4.3.2     Ambulatory Polysomnography Devices
    • 4.5     CONSUMABLES
      • 4.5.1     MASKS
        • 4.5.1.1     Nasal Masks
        • 4.5.1.2     Full Face Mask
        • 4.5.1.3     Nasal Pillow Masks
        • 4.5.1.4     Other Masks
      • 4.5.2     TRACHEOSTOMY TUBE
      • 4.5.3     NASAL CANNULAS
      • 4.5.4     OTHER CONSUMABLES
  • 5     RESPIRATORY CARE DEVICES MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     OBSTRUCTIVE RESPIRATORY CONDITION
      • 5.2.1     ASTHMA
      • 5.2.2     CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
        • 5.2.2.1     Chronic Bronchitis
        • 5.2.2.2     Emphysema
      • 5.2.3     CYSTIC FIBROSIS
      • 5.2.4     OBSTRUCTIVE SLEEP APNEA (OSA)
    • 5.3     RESTRICTIVE RESPIRATORY CONDITION
      • 5.3.1     ARDS
      • 5.3.2     LUNG CANCER
      • 5.3.3     RESTRECTIVE LUNG DISEASES
      • 5.3.4     OTHERS
    • 5.4     VASCULAR DISEASES
      • 5.4.1     PULMONARY FIBROSIS
      • 5.4.2     PULMONARY HYPERTENSION (PH)
      • 5.4.3     PULMONARY EDEMA
    • 5.5     INFECTIOUS RESPIRATORY CONDITION
      • 5.5.1     PNEUMONIA
      • 5.5.2     TUBERCULOSIS
    • 5.6     OTHERS
  • 6     RESPIRATORY CARE DEVICES GLOBAL MARKETY, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
      • 6.2.1     EMERGENCY CARE
      • 6.2.2     CRITICAL CARE/INTENSIVE CARE UNIT (ICU)
      • 6.2.3     ACUTE CARE
      • 6.2.4     SLEEP CENTER UNIT
      • 6.2.5     OTHER HOSPITAL CARE SETTINGS (OPD)
    • 6.3     HOME HEALTH CARE
    • 6.4     AMBULATORY SURGICAL CENTERS
  • 7     REGIONAL MARKET ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     UNITED STATES (U.S.)
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     U.K.
      • 7.3.3     FRANCE
      • 7.3.4     REST OF EUROPE
    • 7.4     ASIA-PACIFIC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     REST OF THE WORLD
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHER COUNTRIES
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
    • 8.2     NEW PRODUCT LAUNCHES
    • 8.3     APPROVALS
    • 8.4     ACQUISITIONS
    • 8.5     AGREEMENTS
    • 8.6     OTHERS
  • 9     MAJOR COMPANIES
    • 9.1     DRAGERWERK AG & CO. KGAA
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     GE HEALTHCARE
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     GETINGE GROUPS (MAQUET GMBH & CO. KG)
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     INOGEN, INC.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MASIMO CORPORATION
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     MEDTRONIC, PLC
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     PHILIPS N.V.
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     RESMED INC.
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     VYAIRE MEDICAL, INC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 2     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 3     THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 4     THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 5     HUMIDIFIER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 6     HUMIDIFIER GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 7     ACTIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 8     PASSIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 9     NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 10     NEBULIZERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 11     JET NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 12     ULTRASONIC NEBULIZER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 13     MESH NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 14     SMART NEBULIZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 15     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 16     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 17     STATIONARY OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 18     PORTABLE OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 19     POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 20     POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 21     CONTINUOUS PAP DEVICES (CPAP) GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 22     CONTINUOUS PAP DEVICES (CPAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
      • TABLE 23     AUTOMATIC PAP (APAP) DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 24     AUTOMATIC PAP DEVICES (APAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
      • TABLE 25     BI-LEVEL PAP (BPAP) DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 26     BI-LEVELPAP DEVICES (BPAP) NUMBER OF UNITS SOLD, BY REGION (2018-2026) (NO’S)
      • TABLE 27     RESUSCITATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 28     RESUSCITATORS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 29     MANUAL RESUSCITATOR GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 30     GAS POWERED RESUSCITATOR GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 31     VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 32     VENTILATORS GLOBAL MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
      • TABLE 33     NON-INVASIVE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 34     INVASIVE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 35     VENTILATORS GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
      • TABLE 36     EMERGENCY CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 37     CRITICAL CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 38     ACUTE CARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 39     AMBULATORY VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 40     HOMECARE VENTILATORS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 41     INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 42     INHALERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 43     DRY POWDER INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 44     METERED DOSE INHALERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 45     SOFT MIST INHALER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 46     OTHER THERAPEUTIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 47     MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 48     MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 49     PULSE OXIMETERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 50     FINGER PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 51     HANDHELD PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 52     WRIST PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 53     TABLETOP PULSE OXIMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 54     CAPNOGRAPHS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 55     GAS ANALYZERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 56     DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 57     DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 58     SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 59     SPIROMETERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 60     VOLUMETRIC SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 61     FLOW MEASURING SPIROMETERS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 62     PEAK FLOW METER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 63     POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 64     POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 65     CLINICAL POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 66     AMBULATORY POLYSOMNOGRAPHS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 67     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 68     CONSUMABLES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 69     MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 70     MASKS GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 71     NASAL MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 72     FUL FACE MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 73     NASAL PILLOW MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 74     OTHER MASKS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 75     TRACHEOSTOMY TUBE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 76     NASAL CANNULAS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 77     OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 78     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 79     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 80     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 81     ASTHMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 82     COPD GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 83     COPD GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 84     CHRONIC BRONCHITIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 85     EMPHYSEMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 86     CYSTIC FIBROSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 87     OBSTRUCTIVE SLEEP APNEA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 88     RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 89     RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 90     ARDS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 91     LUNG CANCER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 92     RESTRICTIVE LUNG DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 93     OTHERS RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 94     VASCULAR DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 95     VASCULAR DISEASES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 96     PULMONARY FIBROSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 97     PULMONARY HYPERTENSION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 98     PULMONARY EDEMA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 99     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 100     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 101     PNEUMONIA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 102     TUBERCULOSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 103     OTHER RESPIRATORY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 104     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 105     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 106     HOSPITALS GLOBAL MARKET REVENUE, BY CARE SETTING, (2018-2026) ($MN)
      • TABLE 107     EMERGENCY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 108     CRITICAL CARE/ICU GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 109     ACUTE CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 110     SLEEP CENTER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 111     OTHER HOSPITAL CARE SETTINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 112     HOME CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 113     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 114     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 115     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 116     NORTH AMERICA THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 117     NORTH AMERICA HUMIDIFIER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 118     NORTH AMERICA OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 119     NORTH AMERICA POSITIVE AIRWAY PRESSURE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 120     NORTH AMERICA RESUSCITATORS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 121     NORTH AMERICA VENTILATORS DEVICE MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
      • TABLE 122      NORTH AMERICA NEBULIZERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 123     NORTH AMERICA INHALERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 124     NORTH AMERICA VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 125     NORTH AMERICA MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 126     NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 127     NORTH AMERICA DIAGNOSTIC RESPRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 128     NORTH AMERICA SPIROMETERS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 129     NORTH AMERICA POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 130     NORTH AMERICA CONSUMABLES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 131     NORTH AMERICA MASKS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 132     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 133     NORTH AMERICA OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 134     NORTH AMERICA COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 135     NORTH AMERICA RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 136     NORTH AMERICA VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 137     NORTH AMERICA INFECTIOUS RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 138     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 139     NORTH AMERICA HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
      • TABLE 140     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 141     EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 142     EUROPE THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 143     EUROPE HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 144     EUROPE OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 145     EUROPE POSITIVE AIRWAY PRESSURE (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 146     EUROPE RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 147     EUROPE VENTILATORS DEVICES MARKET REVENUE, BY INTERPHSE, (2018-2026) ($MN)
      • TABLE 148     EUROPE NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 149     EUROPE INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 150     EUROPE VENTILATORS MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
      • TABLE 151     EUROPE MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 152     EUROPE PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 153     EUROPE DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 154     EUROPE SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 155     EUROPE POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 156     EUROPE CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 157     EUROPE MASKS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 158     EUROPE RESPIRATORY CARE MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 159     EUROPE OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 160     EUROPE COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 161     EUROPE RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 162     EUROPE VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 163     EUROPE INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 164     EUROPE RESPIRATORY CARE DEVICE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 165     EUROPE HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
      • TABLE 166     EUROPE ERESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 167     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 168     APAC THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 169     APAC HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 170     APAC OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 171     APAC POSITIVE AIRWAY PRESSURE (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 172     APAC RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 173     APAC VENTILATORS DEVICES MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
      • TABLE 174     APAC NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 175     APAC INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 176     APAC VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 177     APAC RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 178     APAC PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 179     APAC DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 180     APAC SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 181     APAC POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 182     APAC CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 183     APAC MASKS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 184     APAC RESPIRATORY CARE MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 185     APAC OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE,BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 186     APAC COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 187     APAC RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 188     APAC VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 189     APAC INFECTIOUS RESPIRATORY MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 190     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 191     APAC HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
      • TABLE 192     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 193     ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 194     ROW THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 195     ROW HUMIDIFIER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 196     ROW OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 197     ROW POSITIVE AIRWAY PRESSURE DEVICES (PAP) MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 198     ROW RESUSCITATORS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 199     ROW VENTILATORS DEVICES MARKET REVENUE, BY INTERPHASE, (2018-2026) ($MN)
      • TABLE 200      ROW NEBULIZERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 201     ROW INHALERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 202     ROW VENTILATORS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 203     ROW MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 204     ROW PULSE OXIMETER MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 205     ROW DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 206     ROW SPIROMETERS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 207     ROW POLYSOMNOGRAPH DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 208     ROW CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 209     ROW MASKS MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 210     ROW RESPIRATORY CARE MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 211     ROW OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 212     ROW COPD MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 213     ROW RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 214     ROW VASCULAR DISEASES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 215     ROW INFECTIOUS RESPIRATORY MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
      • TABLE 216     ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 217     ROW HOSPITAL MARKET REVENUE, BY CARE SETTINGS, (2018-2026) ($MN)
      • TABLE 218     ROW RESPIRATORY CARE DEVICE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 219     NEW PRODUCT LAUNCHES (2018-2019)
      • TABLE 220     APPROVALS (2018-2019)
      • TABLE 221     ACQUISITIONS (2018-2019)
      • TABLE 222     AGREEMENTS (2018-2019)
      • TABLE 223     OTHERS (2018-2019)
      • TABLE 224     DRAGERWERK AG & CO. KGAA TOTAL REVENUE AND R&D EXPENSES (2017-2019)(Q2) ($MN)
      • TABLE 225     DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2017-2019)(Q2) ($MN)
      • TABLE 226     DRAGER MEDICAL AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)(Q2) ($MN)
      • TABLE 227     FISHER AND PAYKEL TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 228     FISHER AND PAYKEL TOTAL REVENUE, BY PRODUCTS, (2016-2018) ($MN)
      • TABLE 229     FISHER AND PAYKEL TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 230     GE COMPANY (GE HEALTHCARE): TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
      • TABLE 231     GE COMPANY (GE HEALTHCARE): TOTAL REVENUE, BY SEGMENTS, (2017-2019)(Q2) ($MN)
      • TABLE 232     GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
      • TABLE 233     GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2017-2019)(Q2) ($MN)
      • TABLE 234     GETINGE GROUPS: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019)(Q2) ($MN)
      • TABLE 235     INOGEN, INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
      • TABLE 236     INOGEN, INC.: TOTAL REVENUE, BY REGION, (2017-2019)(Q2) ($MN)
      • TABLE 237     MASIMO CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2017-2019)(Q2) ($MN)
      • TABLE 238     MASIMO CORPORATION: TOTAL REVENUE, BY REGION, (2017-2019)(Q2) ($MN)
      • TABLE 239     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 240     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 241     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 242     PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2017-2019)(Q2) ($MN)
      • TABLE 243     PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2017-2019)Q2) ($MN)
      • TABLE 244     PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)(Q2) ($MN)
      • TABLE 245     RESMED INC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 246     RESMED INC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)

      LIST OF FIGURES

      • FIGURE 1     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: RESPIRATORY CARE DEVICES GLOBAL MARKET
      • FIGURE 3     RESPIRATORY CARE DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     RESPIRATORY CARE DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     RESPIRATORY CARE DEVICES GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     RESPIRATORY CARE DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     RESPIRATORY CARE DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2019) (%)
      • FIGURE 10     VENTILATOR GLOBAL MARKET SHARE, BY KEY PLAYERS (2019) (%)
      • FIGURE 11     PAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2019) (%)
      • FIGURE 12     CPAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2019) (%)
      • FIGURE 13     APAP DEVICES GLOBAL DEVICES MARKET SHARE, BY KEY PLAYERS, (2019) (%)
      • FIGURE 14     BPAP DEVCIES GLOBAL DEVICES MARKET SHARE, BY KEY PLAYERS, (2019) (%)
      • FIGURE 15     RESPIRATORY CARE DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 16     RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY PRODUCT, (2019 V/S 2026), (%)
      • FIGURE 17     THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY PRODUCTS, (2019), (%)
      • FIGURE 18     HUMIDIFIER GLOBAL MARKET SHARE, BY PRODUCTS, (2019 V/S 2026), (%)
      • FIGURE 19     NEBULIZERS DEVICES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2026), (%)
      • FIGURE 20     NEBULIZERS GLOBAL MARKET REVENUE, BY PRODUCTS, (2019 V/S 2026), ($MN)
      • FIGURE 21     JET NUBILZERS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2026), (%)
      • FIGURE 22     ULTRASONIC NEBULIZER GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2026), (%)
      • FIGURE 23     MESH NEBULIZER GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2026), (%)
      • FIGURE 24     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026), ($MN)
      • FIGURE 25     POSITIVE AIRWAY PRESSURE (PAP) DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026), ($MN)
      • FIGURE 26     RESUSCITATORS GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • FIGURE 27     GAS POWERED RESUSCITATOR GLOBAL MARKET SHARE, BY REGION(2019 V/S 2026) (%)
      • FIGURE 28     VENTILATORS GLOBAL MARKET REVENUE, BY INTERPHASE (2018-2026) ($MN)
      • FIGURE 29     VENTILATORS GLOBAL MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
      • FIGURE 30     INHALERS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 31     INHALERS GLOBAL MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 32     DRY POWDER INHALERS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 33     METERED DOSE INHALERS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 34     MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 35     PULSE OXIMETERS GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 36     WRIST PULSE OXIMETERS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 37     GAS ANALYZERS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 38     DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY PRODUCT, (2019 V/S 2026), (%)
      • FIGURE 39     SPIROMETERS GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • FIGURE 40     PEAK FLOW METER GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 41     POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • FIGURE 42     CONSUMABLES GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 43     MASKS GLOBAL MARKET SHARE, BY PRODUCTS, (2019 V/S 2026), (%)
      • FIGURE 44     RESPIRATORY CARE DEVICES MARKET SHARE, BY APPLCATIONS (2019) (%)
      • FIGURE 45     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 46     COPD GLOBAL MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • FIGURE 47     RESTRECTIVE RESPIRATORY CONDITION GLOBAL MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 48     VASCULAR DISEASES GLOBAL MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 49     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET SHARE, BY APPLICATIONS (2018-2026) (%)
      • FIGURE 50     RESPIRATORY CARE DEVICE GLOBAL MARKET SHARE, BY END-USER (2019 VS 2026) (%)
      • FIGURE 51     HOSPITAL GLOBAL MARKET SHARE, BY CARE SETTINGS (2019 VS 2026) (%)
      • FIGURE 52     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 53     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BY REGION AND COUNTRY (2019) ($MN)
      • FIGURE 54     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 55     NORTH AMERICA THERAPEUTIC RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
      • FIGURE 56     NORTH AMERICA HUMIDIFIER, OXYGEN CONCENTRATOR, PAP DEVICES, RESUSCITATOR MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 57     NORTH AMERICA NEBULIZERS, VENTILATORS, INHALERS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 58     NORTH AMERICA VENTILATORS MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
      • FIGURE 59     NORTH AMERICA RESPIRATORY CARE DEVICE MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 60     NORTH AMERICA PULSE OXIMETER MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 61     NORTH AMERICA DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET SHARE, (2019 V/S 2026) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 62     NORTH AMERICA CONSUMABLES AND MASKS MARKET REVENUE, BY PRODUCT (2019) ($MN)
      • FIGURE 63     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 64     NORTH AMERICA OBSTRUCTIVE RESPIRATORY CONDITION AND COPD MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 65     NORTH AMERICA RESTRICTIVE, VASCULAR DISEASES AND INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BY APPLICATIONS (2019 V/S 2026) ($MN)
      • FIGURE 66     NORTH AMERICA RESPIRATORY CARE DEVICE MARKET REVENUE, BY END-USER & HOSPITALS BY CARE SETTINGS (2019 V/S 2026) ($MN)
      • FIGURE 67     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BY COUNRY (2019 V/S 2026) (%)
      • FIGURE 68     U.S. RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 69     U.S. RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 70     U.S. RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 71     REST OF NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 72     REST OF NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 73     REST OF NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USERS (2019 V/S 2026) ($MN)
      • FIGURE 74     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 75     EUROPE THERAPEUTIC RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
      • FIGURE 76     EUROPE HUMIDIFIERS, OXYGEN CONCENTRATORS, PAP DEVICES, RESUSCITATORS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 77     EUROPE NEBULIZERS, VENTILATORS, INHALERS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 78     EUROPE VENTILATORS MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
      • FIGURE 79     EUROPE MONITORING RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 80     EUROPE PULSE OXIMETER MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 81     EUROPE DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET SHARE, (2019 V/S 2026) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 82     EUROPE CONSUMABLES AND MASKS MARKET REVENUE, BY PRODUCTS (2019) ($MN)
      • FIGURE 83     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 84     EUROPE OBSTRUCTIVE RESPIRATORY CONDITION AND COPD MARKET REVENUE, BY APPLICATIONS (2019 V/S 2026) ($MN)
      • FIGURE 85     EUROPE RESTRICTIVE RESPIRATORY CONDITIONS, VASCULAR DISEASES AND INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE,BY APPLICATIONS (2019 V/S 2026) ($MN)
      • FIGURE 86     EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER HOSPITALS MARKET REVENUE, BY CARE SETTINGS (2019 V/S 2026) ($MN)
      • FIGURE 87     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BY COUNRY (2019 V/S 2026) (%)
      • FIGURE 88     GERMANY RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 89     GERMANY RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 90     GERMANY RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 91     U.K. RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 92     U.K. RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 93     U.K. RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 94     FRANCE RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 95     FRANCE RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 96     FRANCE RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 97     REST OF EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 98     REST OF EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 99     REST OF EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 100     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 101     APAC THERAPEUTIC RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
      • FIGURE 102     APAC HUMIDIFIER, OXYGEN CONCENTRATOR, PAP DEVICES, RESUSCITATOR MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 103     APAC NEBULIZERS, VENTILATORS, INHALERS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 104     APAC VENTILATORS MARKET SHARE, BY END-USERS (2019 V/S 2026) (%)
      • FIGURE 105     APAC RESPIRATORY CARE MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 106     APAC PULSE OXIMETER MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 107     APAC DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET SHARE, (2019 V/S 2026) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 108     APAC CONSUMABLES AND MASKS MARKET REVENUE, BY PRODUCTS (2019) ($MN)
      • FIGURE 109     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 110     APAC OBSTRUCTIVE RESPIRATORY CONDITION AND COPD MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 111     APAC RESTRICTIVE CONDITIONS, VASCULAR DISEASES AND INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BY APPLICATIONS (2019 V/S 2026) ($MN)
      • FIGURE 112     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER HOSPITALS MARKET REVENUE, BY CARE SETTINGS (2019 V/S 2026) ($MN)
      • FIGURE 113     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BY COUNRY (2019 V/S 2026) (%)
      • FIGURE 114     JAPAN RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 115     JAPAN RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 116     JAPAN RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 117     CHINA RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 118     CHINA RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 119     CHINA RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 120     INDIA RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 121     INDIA RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 122     INDIA RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 123     REST OF APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 124     REST OF APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 125     REST OF APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 126     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 127     ROW THERAPEUTIC RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
      • FIGURE 128     ROW HUMIDIFIER, OXYGEN CONCENTRATOR, PAP DEVICES, RESUSCITATOR MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 129     ROW NEBULIZERS, VENTILATORS, INHALERS MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 130     ROW VENTILATORS MARKET SHARE, BY END-USERS, (2019 V/S 2026) (%)
      • FIGURE 131     ROW MONITORING RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 132     ROW PULSE OXIMETER MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 133     ROW RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET SHARE, (2019 V/S 2026) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 134     ROW CONSUMABLES AND MASKS MARKET REVENUE, BY PRODUCTS (2019) ($MN)
      • FIGURE 135     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BY APPLICATIONS (2019 V/S 2026) (%)
      • FIGURE 136     ROW OBSTRUCTIVE RESPIRATORY CONDITION AND COPD MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 137     ROW RESTRICTIVE, VASCULAR DISEASES AND INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BY APPLICATIONS (2019 V/S 2026) ($MN)
      • FIGURE 138     ROW RESPIRATORY CARE DEVICE MARKET REVENUE, BY END-USER HOSPITALS MARKET REVENUE, BY CARE SETTINGS (2019 V/S 2026) ($MN)
      • FIGURE 139     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BY COUNRY (2019 V/S 2026) (%)
      • FIGURE 140     BRAZIL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 141     BRAZIL RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 142     BRAZIL RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 143     REST OF LATAM RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 144     REST OF LATAM RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 145     REST OF LATAM RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 146     MIDDLE EAST & OTHERS RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS (2019 V/S 2026) ($MN)
      • FIGURE 147     MIDDLE EAST & OTHERS RESPIRATORY CARE DEVICES MARKET REVENUE, BY APPLICATIONS (2019) ($MN)
      • FIGURE 148     MIDDLE EAST & OTHERS RESPIRATORY CARE DEVICES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 149     KEY GROWTH STRATEGIES, (2018 – 2019)
      • FIGURE 150     SWOT: DRAGERWERK AG & CO. KGAA
      • FIGURE 151     SWOT: FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • FIGURE 152     SWOT: GE HEALTHCARE
      • FIGURE 153     SWOT: GETINGE GROUP
      • FIGURE 154     SWOT: INOGEN INC.,
      • FIGURE 155     SWOT: MASIMO CORP.
      • FIGURE 156     SWOT: MEDTRONIC
      • FIGURE 157     SWOT: PHILIPS N.V.
      • FIGURE 158     SWOT: RESMED INC.,
      • FIGURE 159     SWOT: VYAIRE MEDICAL INC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3B MEDICAL INC.
      • 2     ACARE TECHNOLOGY CO., LTD.
      • 3     AEROBIT HEALTH LTD.
      • 4     AIR LIQUIDE MEDICAL SYSTEMS SA
      • 5     AIRON CORPORATION
      • 6     ALBEDO MEDICAL DEVICES CO.,LTD.
      • 7     ALPHA TRACE MEDICAL SYSTEMS
      • 8     AMBU A/S
      • 9     APEX MEDICAL CORP
      • 10     AVANOS MEDICAL (HALYARD HEALTH)
      • 11     BESCO MEDICAL CO.LTD.
      • 12     BESMED HEALTH BUSINESS CORP.
      • 13     BIO-MED DEVICES, INC.
      • 14     BIRD HEALTHCARE
      • 15     BPL MEDICAL TECHNOLOGIES
      • 16     BUNNELL INC.
      • 17     CAIRE INC.
      • 18     CARL REINER GMBH
      • 19     CHOICEMMED (BEIJING CHOICE ELECTRONIC TECHNOLOGY CO., LTD)
      • 20     CIDELEC
      • 21     CIRCASSIA (AIT THERAPEUTICS, INC.)
      • 22     CLEVELAND MEDICAL DEVICES INC.
      • 23     COMPUMEDICS
      • 24     CONTEC MEDICAL SYSTEMS CO.,LTD
      • 25     CONVEXITY SCIENTIFIC INC.,
      • 26     COSMED SRL
      • 27     CURATIVE MEDICAL INC,
      • 28     DEAS S.R.L.
      • 29     DEYMED DIAGNOSTIC S.R.O
      • 30     DIAMEDICA LIMITED
      • 31     DR BURTON HEALTHCARE LLC
      • 32     DRÄGERWERK AG & CO. KGAA
      • 33     DRIVE MEDICAL (DEVILBISS HEALTHCARE)
      • 34     E-BREATHE SAFETY
      • 35     FANEM LTDA
      • 36     FISHER AND PAYKEL HEALTHCARE
      • 37     FLEXICARE MEDICAL LIMITED
      • 38     FLIGHT-MEDICAL INNOVATIONS LTD.
      • 39     FOREMOUNT ENTERPRISE CO., LTD
      • 40     GALEMED CORPORATION
      • 41     GAS CONTROL EQUIPMENTS LTD (GCE HEALTHCARE)
      • 42     GE HEALTHCARE
      • 43     GERATHERM RESPIRATORY GMBH
      • 44     GETINGE GROUPS (MAQUET GMBH & CO.KG)
      • 45     GF (GRAHAM FIELD) HEALTH PRODUCTS, INC
      • 46     HAMILTON MEDICAL AG
      • 47     HANS RUDOLPH, INC
      • 48     HAYEK INDUSTRIES INC
      • 49     HILLROM (BREATHE TECHNOLOGIES, INC.)
      • 50     HUM GESELLSCHAFT FUR HOMECARE UND MEDIZINTECHNIK GMBH
      • 51     HUNTLEIGH HEALTHCARE LIMITED
      • 52     ICONOVO
      • 53     INOGEN INC.,
      • 54     INSPIRATION HEALTHCARE GROUP PLC
      • 55     INSPIRED MEDICAL
      • 56     INTERSURGICAL LTD
      • 57     JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.
      • 58     KARE MEDICAL AND ANALYTICAL DEVICES LTD. CO.
      • 59     LOWENSTEIN MEDICAL
      • 60     MABIS DMI HEALTHCARE
      • 61     MASIMO CORPORATION
      • 62     MEDICAL DEVELOPMENTS INTERNATIONAL UK LIMITED
      • 63     MEDICAL ECONET GMBH
      • 64     MEDIPINES CORPORATION
      • 65     MEDTRONIC, PLC
      • 66     MEK-ICS CO LTD
      • 67     MERXIN LTD
      • 68     METRAN CO., LTD
      • 69     MGC DIAGNOSTICS
      • 70     MICROBASE TECHNOLOGY CORPORATION
      • 71     MONAGHAN MEDICAL CORPORATION
      • 72     NDD MEDICAL TECHNOLOGIES
      • 73     NIHON KOHDEN CORPORATION
      • 74     NONIN MEDICAL INC
      • 75     NOVO KLINIK-SERVICE GMBH (INNOCATH)
      • 76     NOX MEDICAL
      • 77     NU-MED
      • 78     O2 CONCEPTS. LLC
      • 79     OMRON HEALTHCARE
      • 80     O-TWO MEDICAL TECHNOLOGIES INC.
      • 81     OXITONE MEDICAL LTD
      • 82     PARI RESPIRATORY
      • 83     PARKER MEDICAL TECHNOLOGIES
      • 84     PHILIPS N.V.
      • 85     PRECISION MEDICAL, INC.
      • 86     QINGDAO FUTURE MEDICAL TECHNOLOGY CO. LTD.
      • 87     RESMED, INC
      • 88     SALTER LABS, INC.
      • 89     SCHILLER AG
      • 90     SERVONA GMBH
      • 91     SHENYANG CANTA MEDICAL TECH. CO., LTD.
      • 92     SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD.
      • 93     SHENZHEN HOMED MEDICAL DEVICE CO.LTD.
      • 94     SIBELMED
      • 95     SMITHS GROUP PLC
      • 96     SOMNETICS INTERNATIONAL, INC.
      • 97     SOMNOMEDICS GMBH
      • 98     SOUTHMEDIC INC.
      • 99     SUNSET HEALTHCARE SOLUTIONS INC.
      • 100     SYSMED & CO., LTD.
      • 101     TECME S.A.
      • 102     TELEFLEX INCORPORATED
      • 103     TIMPEL MEDICAL INC.
      • 104     TRUDELL MEDICAL
      • 105     VAPOTHERM INC.
      • 106     VITALOGRAPH, INC.
      • 107     VYAIRE MEDICAL INC.
      • 108     WESTMED, INC.
      • 109     WILAMED GMBH
      • 110     ZOLL MEDICAL CORPORATION